Skybiotech Healthcare Limited

Skybiotech Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Skybiotech Healthcare Limited

₹ 162 -5.00%
09 Jul - close price
kapilcotex.co.in BSE: 512036
About

Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]

Key Points

Business Overview:[1]
SBHCL was engaged in the Textile business and was not generating any revenue from its main business activity. It acquired 72.52% stake in M/s. Skybiotech Lifescience Private Limited which become their subsidiary and is engaged in manufacturing Pharmaceutical Products and ingredients

Website BSE
  • Market Cap ₹ 30.9 Cr.
  • Current Price ₹ 162
  • High / Low ₹ 237 / 116
  • Stock P/E
  • Book Value ₹ 41.8
  • Dividend Yield 0.00 %
  • ROCE -9.32 %
  • ROE -13.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 3.87 times its book value
  • Company has low interest coverage ratio.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 39.5 to 57.1 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Textiles Textiles & Apparels Other Textile Products

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.00 0.00 1.60 2.52 1.02 2.39 1.92 0.96 1.83
0.05 0.04 1.58 2.83 2.11 2.31 2.15 1.41 2.71
Operating Profit -0.05 -0.04 0.02 -0.31 -1.09 0.08 -0.23 -0.45 -0.88
OPM % 1.25% -12.30% -106.86% 3.35% -11.98% -46.88% -48.09%
1.37 0.35 0.04 0.15 -0.18 0.03 0.04 0.08 0.15
Interest 0.00 0.00 0.13 0.11 -0.23 0.01 0.00 0.00 0.00
Depreciation 0.00 0.00 0.13 0.14 0.15 0.12 0.12 0.12 0.12
Profit before tax 1.32 0.31 -0.20 -0.41 -1.19 -0.02 -0.31 -0.49 -0.85
Tax % 18.94% 19.35% 30.00% -4.88% -8.40% 0.00% 0.00% 0.00% -64.71%
1.07 0.25 -0.25 -0.39 -1.08 -0.02 -0.31 -0.48 -0.30
EPS in Rs 5.59 1.31 -1.31 -2.04 -5.64 -0.10 -1.62 -2.51 -1.57
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
0.00 6.96 7.10
0.12 9.21 8.58
Operating Profit -0.12 -2.25 -1.48
OPM % -32.33% -20.85%
2.00 0.38 0.31
Interest 0.00 0.01 0.02
Depreciation 0.00 0.54 0.48
Profit before tax 1.88 -2.42 -1.67
Tax % 18.09% -2.07% -32.93%
1.54 -2.37 -1.12
EPS in Rs 8.04 -12.38 -5.85
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 53%
Stock Price CAGR
10 Years: %
5 Years: 30%
3 Years: 22%
1 Year: -22%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
Equity Capital 1.92 1.92
Reserves 7.07 6.08
7.20 8.42
3.91 3.02
Total Liabilities 20.10 19.44
12.03 11.55
CWIP 0.00 0.00
Investments 2.46 2.24
5.61 5.65
Total Assets 20.10 19.44

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
-1.04 -1.52
-9.63 0.02
1.24 1.17
Net Cash Flow -9.43 -0.33
Free Cash Flow -1.37 -1.52
CFO/OP 46% 103%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
Debtor Days 22.03 57.06
Inventory Days 74.68
Days Payable 79.35
Cash Conversion Cycle 22.03 52.40
Working Capital Days -18.88 -1.03
ROCE % -9.32%

Insights

In beta
Mar 2018 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Investment Portfolio - Cost Value
INR ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Investment Portfolio - Market Value
INR ・Standalone data
Number of Quoted Equity Shares Held (Investment Portfolio)
shares ・Standalone data
Pharmaceutical Domestic Sales
INR Lakhs
Pharmaceutical Export Sales
INR Lakhs
Pharmaceutical Job Work Income
INR Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
57.79% 57.79% 62.71% 62.71% 62.71% 62.71% 62.71% 63.48% 63.48% 63.48% 63.48% 63.48%
42.21% 42.21% 37.29% 37.30% 37.29% 37.29% 37.28% 36.53% 36.52% 36.53% 36.52% 36.53%
No. of Shareholders 310290318320366361660597664615620610

Documents

Announcements

Annual reports